These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8866756)

  • 1. Effects of KSG-504, a new cholecystokinin-A-receptor antagonist, on pancreatic exocrine and endocrine secretions in rats.
    Yamazaki Y; Akahane M; Kobayashi M; Takeda H; Ajisawa Y
    Jpn J Pharmacol; 1996 Feb; 70(2):183-90. PubMed ID: 8866756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new CCK-A antagonist, KSG-504, administered intraduodenally, inhibits pancreatic secretion in rats.
    Moriyoshi Y; Shiratori K; Takeuchi T; Watanabe S
    Pancreas; 1994 Mar; 9(2):225-9. PubMed ID: 8190724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different inhibitory effects of the newly developed CCK receptor antagonists FK480 and KSG-504 on pancreatic exocrine and endocrine secretion in the isolated perfused rat pancreas.
    Kihara Y; Otsuki M
    Pancreas; 1995 Mar; 10(2):109-17. PubMed ID: 7716133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin-A specific antagonism of KSG-504 to cholecystokinin receptor binding and pancreatic secretion in mammals.
    Yamazaki Y; Shinagawa K; Takeda H; Kobayashi M; Akahane M; Ajisawa Y
    Jpn J Pharmacol; 1995 Dec; 69(4):367-73. PubMed ID: 8786640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of KSG-504, a new cholecystokinin-A-receptor antagonist.
    Yamazaki Y; Akahane M; Kobayashi M; Kitazawa M; Kurashina Y; Iizuka K
    Jpn J Pharmacol; 1993 Oct; 63(2):219-25. PubMed ID: 7506805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of KSG-504, a new CCK-A receptor antagonist, on gallbladder and gastrointestinal functions].
    Yamazaki Y; Akahane M; Kobayashi M; Shinagawa K; Sugiura M; Ajisawa Y
    Nihon Yakurigaku Zasshi; 1996 Jan; 107(1):33-44. PubMed ID: 8720296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of KSG-504, a new CCK-A-receptor antagonist, on experimental acute pancreatitis in rats and mice].
    Kobayashi M; Shinagawa K; Sugiura M; Nagasawa T; Akahane M; Ajisawa Y
    Nihon Yakurigaku Zasshi; 1996 Apr; 107(4):183-95. PubMed ID: 8690301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a novel cholecystokinin receptor antagonist, FK480, administered intraduodenally, on pancreatic secretion in rats.
    Moriyoshi Y; Shiratori K; Takeuchi T; Watanabe S
    Pancreas; 1995 Apr; 10(3):295-300. PubMed ID: 7542771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of loxiglumide on pancreatic exocrine secretion stimulated by meal in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Edano K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):55-7. PubMed ID: 9522033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potentiating effect of secretin on cholecystokinin-stimulated exocrine pancreatic secretion in rats].
    Moriyoshi Y
    Nihon Shokakibyo Gakkai Zasshi; 1989 Oct; 86(10):2425-33. PubMed ID: 2480464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of protein derivatives on pancreatic secretion and release of secretin and CCK in rats.
    Shimizu K; Shiratori K; Watanabe S; Takeuchi T; Chang TM; Chey WY
    Am J Physiol; 1994 Oct; 267(4 Pt 1):G508-14. PubMed ID: 7943315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behavioral studies of KSG-504, a new CCK-A receptor antagonist].
    Yamazaki Y; Takeda H; Akahane M; Tsubaki A; Ajisawa Y
    Nihon Yakurigaku Zasshi; 1996 Jan; 107(1):21-31. PubMed ID: 8720295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a new CCK-A receptor antagonist, dexloxiglumide, on the exocrine pancreas in the rat.
    Varga G; Kisfalvi K; D'Amato M; Scarpignato C
    J Physiol Paris; 1997; 91(3-5):257-64. PubMed ID: 9403804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of the inhibitory effect of FK480, a CCK-A receptor antagonist, on pancreatic exocrine secretion by achlorhydria.
    Kuno M; Sogabe H; Ito H; Matsuo T; Satoh Y; Motoyama Y; Tanaka H
    Pancreas; 1998 Jul; 17(1):57-64. PubMed ID: 9667521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of short-term administration of the CCK receptor antagonist, KSG-504, on regeneration of pancreatic acinar cells in acute pancreatitis in rats.
    Okumura Y; Inoue H; Fujiyama Y; Bamba T
    J Gastroenterol; 1995 Aug; 30(4):493-9. PubMed ID: 7550860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin analog, SMS 201-995, inhibits pancreatic exocrine secretion and release of secretin and cholecystokinin in rats.
    Shiratori K; Watanabe S; Takeuchi T
    Pancreas; 1991 Jan; 6(1):23-30. PubMed ID: 1704631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of intraduodenal oligopeptide on rat pancreatic exocrine secretion and release of secretin and CCK].
    Shimizu K
    Nihon Shokakibyo Gakkai Zasshi; 1990 Nov; 87(11):2509-16. PubMed ID: 1703583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CCK antagonists CR 1409 and CR 1505 on rat pancreatic exocrine secretion in vivo.
    Shiratori K; Shimizu K; Watanabe S; Takeuchi T; Moriyoshi Y
    Pancreas; 1989; 4(6):744-50. PubMed ID: 2813333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a new benzodiazepine derivative cholecystokinin receptor antagonist FK480 on pancreatic exocrine secretion in anesthetized rats.
    Tachibana I; Otsuki M
    Dig Dis Sci; 1994 Jun; 39(6):1321-8. PubMed ID: 8200267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.